Does self-medication with cannabis increase paranoia levels? Data from studies on THC and CBD, risk groups, debunked myths, and principles of reducing the risk of paranoid reactions.
Spice, K2, and Mocarz are full CB1 agonists, not cannabis. Seizures in 27% of emergency patients, poisoning symptoms, legal status, and first aid.
CBD and THC in anxiety disorders: doses from studies, results of the 2024 meta-analysis, interactions with medications, and the threshold beyond which a psychiatrist is needed.
What is known about CBD in depression, why the largest study pointed to THC instead of CBD, how the risk of drug interactions looks, and where to seek help in a crisis.
PTSD is a disorder after trauma with established criteria and effective treatment. We check the symptoms, therapy standards, and what studies on CBD really show.
CBD in schizophrenia: what Leweke 2012 and McGuire 2018 studies showed, what doses were used, why THC acts oppositely, and what evidence does not confirm.
CBD for social phobia: what was measured in three small trials, why therapy and SSRIs remain first choice, and when anxiety requires same-day help.
CBD and ADHD without promises: the only randomized trial did not achieve its primary endpoint, and data on anxiety and sleep come from outside ADHD. What does this mean.
Does CBD help with depression? We check what clinical and preclinical studies say, what the doses are, interactions with SSRIs, and where scientific evidence ends.
Czy masz ukończone 18 lat?
Buch z Tobą
